Best Price Antimalarial Artemisinin

Name: Best Price Antimalarial Artemisinin
Brand: Shaanxi Zebrago Industrial Co., Limited
SKU: 875178965

Shaanxi, ChinaShaanxi Zebrago Industrial Co., Limited

US$170.00-230.00

1 kg

Sample price:US$1.00/kg.Request sample

Product profile

Customization

Available

Certification

FDA, HACCP, Kosher

Assay Method

HPLC

Model NO.

Artemisinin

Application Form

Tablet, Capsule

Application

Food, Health Care Products, Medicine

State

Powder

Extract Source

Leaf

Product Name

Artemisia Annua Extract

Botanical Name

Leaf

Active Ingredient

Artemisinin

Purity

98%

Appearance

White Needle Crystalline Powder

Test Method

HPLC

CAS No.

63968-64-9

Molecular Formula

C15h22o5

Solubility

Soluble in Chloroform, Ethyacetate, Benzeneand Ace

Extraction

Solvent Extraction

Function

Anti-Inflammatory and Anti-Cancer

Place of Source

Leaf

Storage

Store in a Cool and Dry Place

Shelf Life

2 Years

Free Sample

10 Grams Available

Transport Package

Drum

Specification

10%

Trademark

Zebrago

Origin

China

HS Code

2932999099

Production Capacity

1000kg/Year

Company profile

High Repeat Buyers ChoiceFast DeliveryCustomization from SamplesQuality Assurance

Shaanxi Zebrago Industrial Co., Limited

Shaanxi, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2014-03-18Nearest Port: Shanghai, Shenzhen, QingdaoAverage Response Time: ≤5.77hTerms of Payment: LC, T/T, D/P, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA

AI-Powered supplier vetting

SummaryShaanxi Zebrago Industrial Co., Limited is a China-based limited trading company/manufacturer with operations in Shaanxi and a factory location in Xianyang. Its stated business covers plant extracts, biomedicine, functional foods, chemicals, peptides, pharmaceutical intermediates, nutritional supplements, and related products. The supplier reports ISO 9000/9001, ISO 14000/14001, GMP, and HACCP certifications, six production lines, 11–20 years of total R&D engineer experience, and 6–10 quality-control staff. Company descriptions also state GMP-designed facilities, national invention patents, a national QS production license, and more than 100 nationally recorded products. SGS conducted an audit with a reported result of 0, valid from April 17, 2025 to April 16, 2026; the meaning of the result code is not provided. Overseas service capability, R&D service details, raw-material traceability, Fortune 500 cooperation, new-product launches, and customer cases remain unverified.

Supplier typeThe supplier is identified as a trading company in its basic information and as both a trading company and manufacturer/factory elsewhere. It operates in health, medicine, chemicals, agriculture, and food-related areas, indicating a mixed trading-and-manufacturing business model.

CertificationsThe supplier reports ISO 9000, ISO 9001, ISO 14000, ISO 14001, GMP, and HACCP certifications, plus a national QS production license. The company also states that its plant is constructed according to GMP requirements and that SGS conducted an audit, although the audit result code is not explained.

Financial creditThe supplier is described as a privately run limited company with registered capital denominated in RMB, and it accepts multiple payment methods including LC, D/P, PayPal, T/T, and Western Union. The information also states that it has been recognized as a contract-abiding and credit-abiding enterprise in Xi'an, but no broader financial verification is provided.

R&D capabilityThe company describes itself as a high-tech and technology-oriented enterprise, reports 11–20 years of total R&D engineer experience, and states that it holds national invention patents and has recorded more than 100 products nationally. Specific evidence for 3D design, new-product launches, ODM, or OEM services is unavailable.

Production capacityThe supplier is identified as a manufacturer/factory and reports six production lines, 6–10 quality-control staff, and a factory in Xianyang, Shaanxi. Its facility is described as covering 200 mu and including R&D, production, sterilization, purification, and other professional areas, supporting substantial production infrastructure.